Loading company…
Synthgene Biotechnology develops materials for immunodiagnostic and in vitro diagnostic products.
Founded in 2018 and based in Wuxi, China, Synthgene Biotechnology develops core materials for immunodiagnostic and in vitro diagnostic reagents and instruments. Its products include mRNA raw materials, sugars, GalNAc, phosphonamidites, nucleosides, molecular diagnostics, succinates and phosphorus reagents. The company closed a venture funding round in March 2026.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in